Hosted on MSN2mon
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disordersIntra-Cellular said last fall it was expanding its sales force to target growth opportunities with primary care doctors. The company also is seeking U.S. Food and Drug Administration approval to ...
20hon MSN
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results